These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 36274479)
1. Trans-[bis(benzimidazol-2-ylidene)dichlorido]platinum(II) complexes with peculiar modes of action and activity against cisplatin-resistant cancer cells. Bär SI; Schleser SW; Oberhuber N; Herrmann A; Schlotte L; Weber SE; Schobert R J Inorg Biochem; 2023 Jan; 238():112028. PubMed ID: 36274479 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, structures and cytotoxic effects in vitro of cis- and trans-[Pt Rehm T; Rothemund M; Dietel T; Kempe R; Schobert R Dalton Trans; 2019 Nov; 48(43):16358-16365. PubMed ID: 31624819 [TBL] [Abstract][Full Text] [Related]
3. Antitumoral effects of mitochondria-targeting neutral and cationic cis-[bis(1,3-dibenzylimidazol-2-ylidene)Cl(L)]Pt(ii) complexes. Rothemund M; Bär SI; Rehm T; Kostrhunova H; Brabec V; Schobert R Dalton Trans; 2020 Jul; 49(26):8901-8910. PubMed ID: 32555811 [TBL] [Abstract][Full Text] [Related]
4. N,N-Dialkylbenzimidazol-2-ylidene platinum complexes - effects of alkyl residues and ancillary cis-ligands on anticancer activity. Rehm T; Rothemund M; Bär A; Dietel T; Kempe R; Kostrhunova H; Brabec V; Kasparkova J; Schobert R Dalton Trans; 2018 Dec; 47(48):17367-17381. PubMed ID: 30480671 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers. Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964 [TBL] [Abstract][Full Text] [Related]
6. Novel cis-[(NHC) Rehm T; Rothemund M; Muenzner JK; Noor A; Kempe R; Schobert R Dalton Trans; 2016 Oct; 45(39):15390-15398. PubMed ID: 27603959 [TBL] [Abstract][Full Text] [Related]
7. Effects of histidin-2-ylidene vs. imidazol-2-ylidene ligands on the anticancer and antivascular activity of complexes of ruthenium, iridium, platinum, and gold. Schmitt F; Donnelly K; Muenzner JK; Rehm T; Novohradsky V; Brabec V; Kasparkova J; Albrecht M; Schobert R; Mueller T J Inorg Biochem; 2016 Oct; 163():221-228. PubMed ID: 27491634 [TBL] [Abstract][Full Text] [Related]
8. Platinum(IV)-nitroxyl complexes as possible candidates to circumvent cisplatin resistance in RT112 bladder cancer cells. Cetraz M; Sen V; Schoch S; Streule K; Golubev V; Hartwig A; Köberle B Arch Toxicol; 2017 Feb; 91(2):785-797. PubMed ID: 27307157 [TBL] [Abstract][Full Text] [Related]
9. Cellular pharmacology of cis and trans pairs of platinum complexes in cisplatin-sensitive and -resistant human ovarian carcinoma cells. O'Neill CF; Hunakova L; Kelland LR Chem Biol Interact; 1999 Nov; 123(1):11-29. PubMed ID: 10597899 [TBL] [Abstract][Full Text] [Related]
10. Dinuclear platinum anticancer complexes with fluorescent N,N'-bis(aminoalkyl)-1,4-diaminoanthraquinones: cellular processing in two cisplatin-resistant cell lines reflects the differences in their resistance profiles. Kalayda GV; Jansen BA; Wielaard P; Tanke HJ; Reedijk J J Biol Inorg Chem; 2005 May; 10(3):305-15. PubMed ID: 15824924 [TBL] [Abstract][Full Text] [Related]
11. Molecular, cellular and pharmacological effects of platinum(II) diiodido complexes containing 9-deazahypoxanthine derivatives: A group of broad-spectrum anticancer active agents. Vančo J; Trávníček Z; Křikavová R; Gáliková J; Dvořák Z; Chalupová M J Photochem Photobiol B; 2017 Aug; 173():423-433. PubMed ID: 28662469 [TBL] [Abstract][Full Text] [Related]
12. Studies on the Complexation of Platinum(II) by Some 4-Nitroisoxazoles and Testing the Cytotoxic Activity of the Resulting Complexes. Mastalarz H; Mastalarz A; Wietrzyk J; Milczarek M; Kochel A; Regiec A Molecules; 2023 Jan; 28(3):. PubMed ID: 36770951 [TBL] [Abstract][Full Text] [Related]
13. Nonclassical platinum antitumor agents: perspectives for design and development of new drugs complementary to cisplatin. Farrell N Cancer Invest; 1993; 11(5):578-89. PubMed ID: 8402226 [TBL] [Abstract][Full Text] [Related]
15. Reactivity and biological properties of a series of cytotoxic PtI2(amine)2 complexes, either cis or trans configured. Messori L; Cubo L; Gabbiani C; Álvarez-Valdés A; Michelucci E; Pieraccini G; Ríos-Luci C; León LG; Padrón JM; Navarro-Ranninger C; Casini A; Quiroga AG Inorg Chem; 2012 Feb; 51(3):1717-26. PubMed ID: 22225466 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes. Kelland LR; Barnard CF; Evans IG; Murrer BA; Theobald BR; Wyer SB; Goddard PM; Jones M; Valenti M; Bryant A J Med Chem; 1995 Aug; 38(16):3016-24. PubMed ID: 7636864 [TBL] [Abstract][Full Text] [Related]
17. A novel isomerization on interaction of antitumor-active azole-bridged dinuclear platinum(II) complexes with 9-ethylguanine. Platinum(II) atom migration from N2 to N3 on 1,2,3-triazole. Komeda S; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J J Am Chem Soc; 2002 May; 124(17):4738-46. PubMed ID: 11971723 [TBL] [Abstract][Full Text] [Related]